be_ixf;ym_202411 d_24; ct_50

Latest Insights on AGN

Biotech Struggles to Recover in 2024 Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 pandemic. Interest in the sector waned over the last few years — due in part to sharply increased interest rates and the rapid emergence of the AI mega trend. But now, the smart money is starting to flow back into the sector...
Chaos Strikes Super Micro (Again) Super Micro surged for a 1,300% gain in under two years - but now it's crashing (yet again). Here's what's coming next...
Why This Tech Market Darling Has Our Lowest Rating Intel was once one of the market's hottest tech stocks, a key player in the early era of personal computing. But now the market is transforming, and Intel's dominance of the desktop computer is growing less relevant. And according to Adam O'Dell's Green Zone Power Ratings system, it's one of the worst investments you could make in the market today...
Buffett Can’t Cash in on These Stocks (But YOU Can) Despite Buffett’s vast fortune and his army of stock analysts, there’s still ONE critical advantage you have over the “Oracle of Omaha”...
3 Surprising Ways The Market Reacts to Elections With both campaigns now entering the final stretch, you can expect to be inundated with political advertising and mind-numbing media coverage for the next two months. So today, Matt Clark is diving into the data to share 3 surprising lessons about how your investments will handle this year's election...

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

Share This